Faculty who have authored publication Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Name | Title | Department | Institution |
---|---|---|---|
Razelle Kurzrock MD | Center Associate Director, Professor | Medicine | Medical College of Wisconsin |